BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6467768)

  • 1. Rapid prediction of individual dosage requirements for lignocaine.
    Vozeh S; Berger M; Wenk M; Ritz R; Follath F
    Clin Pharmacokinet; 1984; 9(4):354-63. PubMed ID: 6467768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study for validation of Bayesian prediction approach to adjust individual lidocaine dosage.
    Uematsu T; Hirayama H; Umemura K; Kosuge K; Nakashima M
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):33-7. PubMed ID: 8199750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of individual dosage requirements for lignocaine: a validation study for Bayesian forecasting in Japanese patients.
    Uematsu T; Hirayama H; Nagashima S; Yamazaki T; Tsuchiya N; Sato R; Nakashima M
    Ther Drug Monit; 1989; 11(1):25-31. PubMed ID: 2911849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
    Bax ND; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring.
    Joel SE; Bryson SM; Small M; Hillis WS; Kelman AW; Whiting B
    Ther Drug Monit; 1983; 5(3):271-7. PubMed ID: 6636255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
    Upward JW; Holt D; Emery P; Akhras F; Jackson G
    Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lidocaine infusions: effect of duration and method of discontinuation on recurrence of arrhythmias and pharmacokinetic variables.
    Fredrick DS; Boersma RB
    Am J Hosp Pharm; 1979 Jun; 36(6):778-81. PubMed ID: 463893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the prediction interval.
    Vozeh S; Uematsu T; Hauf GF; Follath F
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):203-12. PubMed ID: 4057058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple method for maintaining serum lidocaine levels in the therapeutic range.
    Wong BY; Hurwitz A
    Arch Intern Med; 1985 Sep; 145(9):1588-91. PubMed ID: 4026487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous lignocaine for chronic pain: an 18-month experience].
    Cahana A; Shvelzon V; Dolberg O; Magora F; Shir Y
    Harefuah; 1998 May; 134(9):692-4, 751, 750. PubMed ID: 10909615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Logical approach to lignocaine therapy.
    Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F
    Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of intramuscular lidocaine in the acute stage of myocardial infarction].
    Djiane P; Egre A; Perchicot B; Bory M; Serradimigni A; Bruguerolle B; Bouyard P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):931-8. PubMed ID: 6793010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics of lignocaine.
    Benowitz NL; Meister W
    Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lignocaine in the treatment of arrhythmia].
    Gürtler-Krawczyńska E
    Wiad Lek; 1971 Jun; 24(12):1205-9. PubMed ID: 5561278
    [No Abstract]   [Full Text] [Related]  

  • 15. Lignocaine kinetics in cardiac patients and aged subjects.
    Nation RL; Triggs EJ; Selig M
    Br J Clin Pharmacol; 1977 Aug; 4(4):439-48. PubMed ID: 901735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lignocaine: a new technique for intravenous administration.
    Levy RA; Charuzi Y; Mandel WJ
    Br Heart J; 1977 Sep; 39(9):1026-8. PubMed ID: 907767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer-assisted drug assay interpretation based on Bayesian estimation of individual pharmacokinetics: application to lidocaine.
    Vozeh S; Hillman R; Wandell M; Ludden T; Sheiner L
    Ther Drug Monit; 1985; 7(1):66-73. PubMed ID: 3838832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computer-assisted individualized lidocaine dosage: clinical evaluation and comparison with physician performance.
    Vozeh S; Uematsu T; Ritz R; Schmidlin O; Kaufman G; Scholer A; Follath F
    Am Heart J; 1987 Apr; 113(4):928-33. PubMed ID: 3565242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic approach to the clinical use of lidocaine intravenously.
    Greenblatt DJ; Bolognini V; Koch-Weser J; Harmatz JS
    JAMA; 1976 Jul; 236(3):273-7. PubMed ID: 947029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.